Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea

PURPOSE: Neuromuscular immune-related adverse events (irAEs) associated with immune checkpoint inhibitors (ICIs) have been increasingly recognized as a consequence of expanding use of ICIs in advanced cancers. We aimed to evaluate the frequency, phenotypes, rescue treatment, and clinical outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyun, Jae-Won, Kim, Ki Hoon, Kim, Su-Hyun, Kim, Ho Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356664/
https://www.ncbi.nlm.nih.gov/pubmed/36495331
http://dx.doi.org/10.1007/s00432-022-04516-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356664/
https://www.ncbi.nlm.nih.gov/pubmed/36495331
http://dx.doi.org/10.1007/s00432-022-04516-x

Ejemplares similares